Is MK-677 FDA approved?
No. This profile records MK-677 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Healing CATEGORY
MK-677
THE BUILDER
Ibutamoren; Oratrope
MK-677 is an orally active compound that mimics ghrelin and stimulates your body to produce more growth hormone and IGF-1. Unlike injecting synthetic HGH, this triggers your natural pulsatile GH release. Users report better sleep, faster recovery, increased muscle mass, and improved body composition. It's one of the most popular compounds for anti-aging and bodybuilding.
MK-677
MK-677
MK-677
MK-677 Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
2 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About MK-677
What dose does The Peptide App Clinical Team recommend for MK-677?
Dose: 10-25 mg daily (oral).
MORE CONTEXT ›
Schedule: daily. Cycle: 8-12 weeks on, 4-8 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this MK-677 guide?
This guide links to 2 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
GH Secretion
Activates ghrelin receptors to stimulate pulsatile growth hormone release
IGF-1 Elevation
Increases IGF-1 levels for muscle growth and recovery
Sleep Enhancement
Improves deep sleep quality when GH peaks
Bone Density
Supports increased bone mineral density over time
Those wanting to increase natural growth hormone
Athletes and bodybuilders seeking muscle gains
People with poor sleep quality
Those over 30 experiencing age-related decline
Anyone wanting faster recovery from training
MK-677 Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES